## **Core Concept**
The question assesses knowledge of major trials related to risk factor intervention for coronary heart disease (CHD). These trials aim to evaluate the effectiveness of various interventions in reducing cardiovascular risk factors and events. Understanding the specifics of these trials is crucial for managing and preventing CHD.

## **Why the Correct Answer is Right**
The correct answer, , refers to the specific trial that does not fit with the others in the context of risk factor intervention for coronary heart diseases. Without the specific trial names provided in the question, we can infer that the question seeks to identify a trial that either does not primarily focus on coronary heart disease risk factor intervention or does not align with the others in terms of study design, population, or intervention type.

## **Why Each Wrong Option is Incorrect**
- **Option A:** , , and are trials that have been conducted to assess the impact of various interventions on cardiovascular risk factors and events. Each of these trials has contributed valuable information on the management and prevention of coronary heart disease. If one of these is not primarily focused on CHD risk factor intervention, it would be incorrect in this context.
- **Option B:** Similarly, if this option represents a trial that is directly related to CHD risk factor intervention, it would be a wrong choice as an exception.
- **Option C:** This option, like the others, would be incorrect if it represents a trial that aligns with the goals of CHD risk factor intervention.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that landmark trials such as the **Framingham Heart Study**, **4S (Scandinavian Simvastatin Survival Study)**, and **WOSCOP (West of Scotland Coronary Prevention Study)** have significantly shaped our understanding of CHD risk factors and the effectiveness of interventions like statins in primary and secondary prevention.

## **Correct Answer:** .